Dokładna liczba przypadków opryszczki narządów płciowych z pewnością jest niedoszacowana nie tylko w Polsce, lecz także w innych krajach. Wiąże się to z brakiem obowiązku zgłaszania choroby, trudnościami w jej rozpoznaniu oraz ograniczonymi możliwościami diagnostycznymi. Ocenę seroepidemiologiczną mogą ułatwić dokładne, specyficzne dla danego typu HSV testy ELISA (enzyme-linked immunosorbent assay), które stają się coraz bardziej powszechne.

Nawracające objawy opryszczki narządów płciowych bywają przyczyną silnego dyskomfortu, psychicznego stresu i stygmatyzacji społecznej. Czynniki te mogą mieć istotny wpływ na jakość życia i relacje seksualne.

ABSTRACT

Genital herpes in specific patient groups

Genital herpes infection is the most common viral infection and the most common cause of erosions and ulcers in the genital area. The percentage of infected adults is approximately 14% and varies according to gender, age, geographical and socioeconomic conditions. The incidence in Poland is underestimated due to the absence of an obligation to report infections, difficulties with establishing a correct diagnosis and the lack of public information campaigns through the mass media. The purpose of this paper is to describe the presentation of the infection and to evaluate the prevalence of the virus in individual patient groups.

Piśmiennictwo

1. Davison AJ. Herpesvirus systematics. Vet Microbiol 2010;143:52-69

2. Avitabile E, Forghieri C, Campadelli-Fiume G. Complexes between herpes simplex virus glycoproteins gD, gB, and gH detected in cells by complementation of split enhanced green fluorescent protein. J Virol 2007;81:11532-7

3. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley PM, Cohen JI et al. Fields virology. 6th ed. Philadelphia: Lippincott-Williams &Wilkins, 2013:1823-97

4. Żaba R. Opryszczka, półpasiec, ospa wietrzna. Poznań: Termedia, 2011

5. Donovan B. Sexually transmissible infections other than HIV. Lancet 2004;363:545-56

6. Bernstein DI, Bellamy AR, Hook EW et al. Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women. Clin Infect Dis 2013;56:344-51

7. World Health Organization. Sexually transmitted infections management guidelines 2020. http://www.who.int/ HIV_AIDS

8. Looker KJ, Magaret AS, May MT et al. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One 2015 Oct 28;10(10):e0140765

9. Weiss HA, Buve N, Robinson NJ. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001;15(Suppl 4):97-108

10. Smith JS, Rosińska M, Trzcińska A et al. Type specific seroprevalence of HSV1 and HSV2 in four geographical regions of Poland. Sex Transm Infect 2006;82:159-63

11. Mertz GJ, Rosenthal SL, Stanberry LR. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis 2003;30:801-2

12. Kimberlin DW, Baley J. Committee on Infectious Diseases; Committee on Fetus and Newborn: Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 2013;131:383-6

13. Scott-Sheldon LA, Huedo-Medina TB, Warren MR et al. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr 2011;58:489-98

14. Dwyer DE, Cunningham AL. Herpes simplex and varicella-zoster virus infections. Med J Aust 2002;177:267-73

15. Sebitloane MH. HIV and gynaecological infections. Best Pract Res Clin Obstet Gynecol 2005;19:231-41

16. Looker KJ, Magaret AS, May MT et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 2017;5:300-9

17. Snoeck R. Antiviral therapy of herpes simplex. Int J Antimicrob Agents 2000;16:157-9

18. Belshe RB, Leone PA, Bernstein DI et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012;366:34-43

Do góry